Letters to the Editor
Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(7–9):8. Dear Editor: We report the case of a 70-year-old patient affected by ocular myasthenia gravis (MG), diagnosed three years ago due to double vision […]
Letter to the Editor: Innovative Rehabilitation Technologies in the COVID-19 Era: Two Sides of the Same Coin
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(4–6):8–9. Dear Editor: In the neuroscience field, the last 10 years have been dominated by the “great mantra” of neuroplasticity. Researchers and clinicians wanted to have […]
Letter to the Editor: Orthognathic Surgery for Patients with Neurodevelopmental Disorders Requires Careful Decision-making by a Multidisciplinary Team
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(4–6):9–10. Dear Editor: In recent decades, the prevalence of neurodevelopmental disorders, including attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), has been increasing.1 Patients […]
Letter to the Editor: Elevated Level of CXCL13 in Nonenhancing Diffuse Primary Lymphoma of the Brainstem
Innov Clin Neurosci. 2021;18(10–12):8. Dear Editor: Primary central nervous system (CNS) lymphoma (pCNL) is a rare neoplasia predominantly of the brain. Histologically, most of these neoplasias are diffuse large B-cell lymphomas.1 Although the exact diagnosis requires pathological confirmation, magnetic resonance imaging (MRI) often shows characteristic results, such as enhancement.2 However, nonenhancing pCNL have been described […]
Letter to the Editor: Beyond Robotics and Virtual Reality: It’s Time to go Back to the Patient!
Dear Editor: There is great scientific activity regarding robotics, virtual reality (VR), telehealth, and digital medicine.1–2 A “mischievous” point of view could tell that they are running after the real life, like the poor boy’s finger in the Harlem Dam hole. Evidence-based medicine, cost/efficacy ratio, and consensus papers are trying to put the hat over […]
Letter to the Editor: Beware of Neuroleptic Malignant Syndrome in COVID-19 Pandemic
Dear Editor: I read with great interest the recent article by Buttar et al1 detailing fatal consequences of the chronic neuroleptic malignant syndrome (NMS) from the United States. The authors prescribed the challenges of treating psychiatric patients with the possibility of NMS. They also indicated that ethnic groups concerning metabolic enzyme polymorphisms for antipsychotics, such […]
Letter to the Editor: Adjunct Ketamine in Electroconvulsive Therapy
Dear Editor: Electroconvulsive therapy (ECT) is a medical treatment that involves the electrical stimulation of the brain under general anesthesia. This treatment modality has been utilized worldwide for over 80 years.1 According to the American Psychiatric Association, ECT is indicated for major depression, mania, and schizophrenia.2 Unfortunately, there are occasions in which a psychiatrist is […]
Letters to the Editor: Sexual Behavior During the COVID-19 Pandemic: It’s Telecounseling Time!
Dear Editor: COVID-19 is having a tremendous impact on the healthcare and economic systems worldwide, as well as on human behavior, negatively affecting both personal and social relationships. COVID-19 is an acute respiratory illness caused by the SARS-COV2, with transmission that occurs via droplets or direct contact with contaminated objects (i.e., fomites).1 As such, first-line […]
Letters to the Editor: What About Biomarkers for Parkinson’s Disease?
Dear Editor: Parkinson’s disease (PD) affects over 600,000 patients in the United States; these numbers might double by 2040, as the population of older people increases.1 Diagnostic clues include the signs of resting tremor, bradykinesia, muscle rigidity, and postural imbalance. However, these clinical indicators might be inaccurate much of the time. A low rate of […]
Letters to the Editor: Nonresponsive myasthenia is suspicious for congenital myasthenic syndrome or myopathy
Dear Editor: We read the excellent article by Diaz-Abad et al1 about a 54-year-old male patient with double seronegative myasthenia gravis. In the article, Diaz et al1 explained the patient did not tolerate pyridostigmine or steroids and did not respond sufficiently to immunoglobulins or plasmapheresis. However, respiratory failure (due to involvement of the respiratory muscles), […]
